France raises a revolutionary banner over In Vitro Diagnostics (IVD) Directive
This article was originally published in Clinica
Industry in Europe may be facing a period of regulatory upheaval after French moves to toughen the new In Vitro Diagnostics Directive. The logic behind these moves could have far-reaching effects for the future, and could even affect the way medical devices are regulated.
You may also be interested in...
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.
The US Food and Drug Administration posted two device-related closeout letters in November.
Jazz and PharmaMar need to see what further data will be needed to convert their FDA authorization into a full approval following disappointing results in the ATLANTIS Phase III trial.